Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
from NYT > Well https://ift.tt/kwGinRK
via IFTTT
Monday, April 18, 2022
Scientists Question Data Behind an Experimental Alzheimer’s Drug
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment